1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antkiewicz-Michaluk, L; Michaluk, J; Nalepa, I; Romańska, I; Wąsik, A; Zelek-Molik, A | 1 |
| Antkiewicz-Michaluk, L; Romańska, I; Wąsik, A | 1 |
| Fujitani, M; Kotake, Y; Makino, Y; Ohta, S; Shintani, H; Yamakawa, T | 1 |
3 other study(ies) available for 1,2,3,4-tetrahydro-1-(phenylmethyl)isoquinoline and Parkinsonian Disorders
| Article | Year |
|---|---|
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Hyperkinesis; Male; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Tetrahydroisoquinolines | 2016 |
Comparison of the Effects of Acute and Chronic Administration of Tetrahydroisoquinoline Amines on the In Vivo Dopamine Release: A Microdialysis Study in the Rat Striatum.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Agents; Male; Microdialysis; Motor Activity; Neuroprotective Agents; Parkinsonian Disorders; Rats, Wistar; Tetrahydroisoquinolines; Time Factors | 2016 |
Regional distribution of parkinsonism-preventing endogenous tetrahydroisoquinoline derivatives and an endogenous parkinsonism-preventing substance-synthesizing enzyme in monkey brain.
Topics: Animals; Brain; Isoquinolines; Macaca fascicularis; Parkinsonian Disorders; Tetrahydroisoquinolines; Tissue Distribution | 1999 |